Raffa Wealth Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Raffa Wealth Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-251	Closed	-$9.75K	–	1176
2025 Q3	$9.75K	Sell	251 -1	-0.4%	-$36	﹤0.01%	373
2025 Q2	$8.49K	Hold	252	–	–	﹤0.01%	409
2025 Q1	$8.01K	Hold	252	–	–	﹤0.01%	351
2024 Q4	$9.78K	Hold	252	–	–	﹤0.01%	329
2024 Q3	$11.3K	Hold	252	–	–	﹤0.01%	301
2024 Q2	$10.5K	Hold	252	–	–	﹤0.01%	436
2024 Q1	$11.5K	Hold	252	–	–	﹤0.01%	410
2023 Q4	$11.6K	Hold	252	–	–	﹤0.01%	272
2023 Q3	$10.2K	Hold	252	–	–	﹤0.01%	275
2023 Q2	$12.2K	Hold	252	–	–	﹤0.01%	253
2023 Q1	$12.4K	Hold	252	–	–	﹤0.01%	263
2022 Q4	$12.7K	Hold	252	–	–	0.01%	252
2022 Q3	$12.6K	Hold	252	–	–	0.01%	246
2022 Q2	$12.3K	Hold	252	–	–	0.01%	258
2022 Q1	$15.1K	Hold	252	–	–	0.01%	240
2021 Q4	$20K	Hold	252	–	–	0.01%	224
2021 Q3	$22.3K	Hold	252	–	–	0.01%	181
2021 Q2	$25.1K	Hold	252	–	–	0.01%	180
2021 Q1	$22.6K	Buy	+252	New	+$24.9K	0.01%	186

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.7B AUM 25.67% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $9.93B AUM 28.91% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Raffa Wealth Management's GNOM Position: Q4 2025 in Review

Raffa Wealth Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q4 2025, closing a stake of 251 shares — an estimated $9.75K sold.

Raffa Wealth Management first reported a position in GNOM in Q1 2021 and held it in 19 quarters. The position peaked at $25.1K in Q2 2021. 40 funds tracked by Wall St. Rank hold GNOM as of Q4 2025.

Raffa Wealth Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q4 2025 after selling out during the quarter.
Raffa Wealth Management sold 251 Global X Genomics & Biotechnology ETF shares in Q4 2025, an estimated $9.75K.
Raffa Wealth Management first reported a position in Global X Genomics & Biotechnology ETF in Q1 2021 and held it in 19 quarters.
Raffa Wealth Management's Global X Genomics & Biotechnology ETF position peaked at $25.1K in Q2 2021.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q4 2025.

Based on Raffa Wealth Management's 13F filing for Q4 2025, filed 27 Jul 2026.